Free Trial

Molina Healthcare (MOH) Stock Forecast & Price Target

$326.23
+0.97 (+0.30%)
(As of 09:46 AM ET)

Molina Healthcare - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
6
Buy
6

Based on 13 Wall Street analysts who have issued ratings for Molina Healthcare in the last 12 months, the stock has a consensus rating of "Hold." Out of the 13 analysts, 1 has given a sell rating, 6 have given a hold rating, 5 have given a buy rating, and 1 has given a strong buy rating for MOH.

Consensus Price Target

$378.00
15.42% Upside
According to the 13 analysts' twelve-month price targets for Molina Healthcare, the average price target is $378.00. The highest price target for MOH is $439.00, while the lowest price target for MOH is $297.00. The average price target represents a forecasted upside of 15.42% from the current price of $326.23.
Get the Latest News and Ratings for MOH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Molina Healthcare and its competitors.

Sign Up

MOH Analyst Ratings Over Time

TypeCurrent Forecast
10/9/23 to 10/8/24
1 Month Ago
9/9/23 to 9/8/24
3 Months Ago
7/11/23 to 7/10/24
1 Year Ago
10/9/22 to 10/9/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$378.00$378.00$405.18$349.38
Forecasted Upside15.42% Upside15.43% Upside41.29% Upside3.32% Upside
Consensus Rating
Hold
Hold
Moderate Buy
Hold

MOH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MOH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Molina Healthcare Stock vs. The Competition

TypeMolina HealthcareMedical CompaniesS&P 500
Consensus Rating Score
2.46
2.78
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside16.28% Upside10,695.92% Upside7.99% Upside
News Sentiment Rating
Positive News

See Recent MOH News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/1/2024Cantor Fitzgerald
3 of 5 stars
 Reiterated RatingOverweight ➝ Overweight$406.00 ➝ $406.00+17.52%
8/5/2024Wells Fargo & Company
3 of 5 stars
 Boost TargetEqual Weight ➝ Equal Weight$315.00 ➝ $360.00+2.59%
7/29/2024Deutsche Bank Aktiengesellschaft
2 of 5 stars
 Lower TargetHold ➝ Hold$354.00 ➝ $353.00+6.02%
7/25/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$320.00 ➝ $320.00-1.32%
7/24/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$354.00 ➝ $297.00+2.86%
7/24/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$412.00 ➝ $351.00+21.57%
7/15/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$440.00 ➝ $400.00+36.52%
7/10/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$420.00 ➝ $395.00+38.68%
5/30/2024Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/30/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$405.00+28.50%
4/25/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$437.00 ➝ $430.00+21.64%
3/28/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underperform$439.00+4.90%
12/21/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$350.00 ➝ $380.00+7.26%
7/14/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$365.00+21.87%
4/28/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$347.00 ➝ $350.00+17.88%
11/7/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$371.00 ➝ $380.00+14.96%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:12 AM ET.


Should I Buy Molina Healthcare Stock? MOH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, October 7, 2024. Please send any questions or comments about these Molina Healthcare pros and cons to contact@marketbeat.com.

Molina Healthcare
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Molina Healthcare, Inc.:

  • Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.
  • The company operates in four segments: Medicaid, Medicare, Marketplace, and Other, providing diversified revenue streams.
  • Recent developments in the company's operations have shown growth potential in serving a broader population.
  • Molina Healthcare, Inc. has been expanding its presence in various states, increasing its market reach and potential customer base.
  • The current stock price of Molina Healthcare, Inc. is favorable for investors looking for potential growth opportunities.

Molina Healthcare
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Molina Healthcare, Inc. for these reasons:

  • While the company serves low-income families, changes in government policies and regulations could impact its revenue and profitability.
  • Competition in the healthcare industry is intense, and Molina Healthcare, Inc. may face challenges in maintaining its market position.
  • Fluctuations in healthcare spending and reimbursement rates could affect the financial performance of the company.
  • Investing in healthcare companies involves risks related to regulatory changes, litigation, and other industry-specific factors.
  • Despite recent growth, Molina Healthcare, Inc. may still face uncertainties in the healthcare market that could impact its future prospects.

MOH Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Molina Healthcare is $378.00, with a high forecast of $439.00 and a low forecast of $297.00.

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Molina Healthcare in the last twelve months. There is currently 1 sell rating, 6 hold ratings, 5 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" MOH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MOH, but not buy additional shares or sell existing shares.

According to analysts, Molina Healthcare's stock has a predicted upside of 15.87% based on their 12-month stock forecasts.

Molina Healthcare has been rated by research analysts at Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, JPMorgan Chase & Co., Stephens, TD Cowen, Truist Financial, and Wells Fargo & Company in the past 90 days.

Analysts like Molina Healthcare less than other "medical" companies. The consensus rating for Molina Healthcare is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MOH compares to other companies.


This page (NYSE:MOH) was last updated on 10/8/2024 by MarketBeat.com Staff
From Our Partners